BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36030465)

  • 1. Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib.
    Molho-Pessach V; Hartshtark S; Merims S; Lotem M; Caplan N; Alfassi H; Maly A; Goldstein G; Muskatel RS
    Br J Dermatol; 2022 Dec; 187(6):1052-1054. PubMed ID: 36030465
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population.
    Wu D; Wang M; Wang X; Yin N; Song T; Li H; Yu J; Wang DM; Zhao Z
    Am J Dermatopathol; 2011 Jun; 33(4):341-4. PubMed ID: 21430505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
    Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
    Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway Inhibition.
    Martin SB; Polubothu S; Bruzos AL; Kelly G; Horswell S; Sauvadet A; Bryant D; Zecchin D; Riachi M; Michailidis F; Sadri A; Muwanga-Nanyonjo N; Lopez-Balboa P; Knöpfel N; Bulstrode N; Pittman A; Yeh I; Kinsler VA
    J Invest Dermatol; 2024 Mar; 144(3):593-600.e7. PubMed ID: 37716647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.
    Dessars B; De Raeve LE; El Housni H; Debouck CJ; Sidon PJ; Morandini R; Roseeuw D; Ghanem GE; Vassart G; Heimann P
    J Invest Dermatol; 2007 Jun; 127(6):1468-70. PubMed ID: 17301836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation.
    Krengel S; Widmer DS; Kerl K; Levesque MP; Schiestl C; Weibel L
    Br J Dermatol; 2016 Mar; 174(3):642-4. PubMed ID: 26302237
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi.
    Papp T; Schipper H; Kumar K; Schiffmann D; Zimmermann R
    Melanoma Res; 2005 Oct; 15(5):401-7. PubMed ID: 16179867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.
    Mochel MC; Hammond MR; Frederick DT; Alora-Palli MB; Piris A; Flaherty KT; Hoang MP
    J Am Acad Dermatol; 2015 Sep; 73(3):491-9.e2. PubMed ID: 26190239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
    de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
    Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo.
    Hafner C; Stoehr R; van Oers JM; Zwarthoff EC; Hofstaedter F; Klein C; Landthaler M; Hartmann A; Vogt T
    J Invest Dermatol; 2009 Nov; 129(11):2730-5. PubMed ID: 19536147
    [No Abstract]   [Full Text] [Related]  

  • 11. Congenital melanocytic naevus syndrome, is there a role for trametinib monotherapy?
    Copland E; Pearson B
    J Paediatr Child Health; 2023 Apr; 59(4):697-699. PubMed ID: 37010082
    [No Abstract]   [Full Text] [Related]  

  • 12. B-RAF and melanocytic neoplasia.
    Gill M; Celebi JT
    J Am Acad Dermatol; 2005 Jul; 53(1):108-14. PubMed ID: 15965430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant Congenital Melanocytic Nevus Treated With Trametinib.
    Mir A; Agim NG; Kane AA; Josephs SC; Park JY; Ludwig K
    Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30792255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.
    Yeh I; von Deimling A; Bastian BC
    J Natl Cancer Inst; 2013 Jun; 105(12):917-9. PubMed ID: 23690527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
    Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
    Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Genomic Profiling of Melanocytic Nevi.
    Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
    J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage.
    De Raeve LE; Claes A; Ruiter DJ; van Muijen GN; Roseeuw D; van Kempen LC
    Br J Dermatol; 2006 Mar; 154(3):485-92. PubMed ID: 16445780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDR2 mutation in a spilus-type giant congenital melanocytic nevus.
    Gallo-Pineda G; Ortiz-Prieto A; Villegas-Romero I; Navarro-Navarro I; Linares-Barrios M
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e793-e794. PubMed ID: 35620941
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
    Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
    J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Phacomatosis Pigmentokeratotica as the Expression of a Mosaic RASopathy With the BRAF-Glu586Lys Mutation.
    Ayala D; Ramón MD; Martín JM; Jordá E
    Actas Dermosifiliogr; 2016 May; 107(4):344-6. PubMed ID: 26703821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.